Refine by
Spinal Cord Injury Articles & Analysis
34 news found
Europe-wide aid project for the protection of people with paraplegia Cologne, 28/05/2020 – COVID-19 can be particularly dangerous for people with severe spinal cord injuries. That is why FARCO-PHARMA supports the European Spinal Cord Injury Federation (ESCIF) and the Association of ...
He is on the Board of Directors for the German Spinal Cord Injury Foundation and is Chair of the International Standards Committee at the American Spinal Injury Association (ASIA). ...
ABLE Human Motion has created the ABLE Exoskeleton, an innovative bilateral lower-limb exoskeleton for individuals with spinal cord injury that offers unheard characteristics in terms of weight, usability and price. ...
I worked for more than 10 years in a foundation dedicated to the rehabilitation of people with spinal cord injury and other pathologies of neurological origin. What role does physical therapy play in the daily life of a person with spinal cord injury? ...
After creating 7 iterative versions of the exoskeleton prototype that have been tested in individuals with spinal cord injury to validate product-market fit and receive early feedback in order to adapt, change and redesign the device, we have frozen the design of the ABLE Exoskeleton. ...
In recent days, numerous media have reported the news of a great advance for science, and especially for all those people with spinal cord injury and their medical and caregiver teams. The ONWARD team has developed an epidural electrical stimulation system using electrodes placed in the epidural space (between the vertebrae and the ...
September is National Spinal Cord Injury (SCI) Awareness Month. With over 17,000 new spinal cord injuries taking place every year in the U.S., there is a significant need to call attention to the severity of spinal cord injuries and for ...
These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include five allogeneic ...
These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include five allogeneic ...
These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include five allogeneic ...
These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include four allogeneic ...
Similar to OpRegen, which has demonstrated to be able to replace and restore retinal pigment epithelium cells in patients with vision loss, and OPC1, which similarly replaces oligodendrocytes for the treatment of spinal cord injury, replacing auditory neurons or augmenting an existing but damaged auditory neuron population may provide a benefit ...
Millions of people rely on self-catheterization to empty their bladder due to conditions such as urinary bladder retention, spinal cord injury, traumatic brain injury, multiple sclerosis, and more. ...
Culley continued, “Looking ahead, Lineage will remain focused on advancing our spinal cord injury and oncology programs as well as announcing new disease settings where we plan to deploy our technology, either on our own or through strategic alliances. ...
Priest led the preclinical cellular therapeutics group at Geron Corporation, working on treatments for spinal cord injury, cardiovascular disease and diabetes. During that time, Geron developed the first successful IND application for an embryonic stem cell-derived cellular therapeutic that was approved by the U.S. ...
There are an estimated 5.35 million1 people in the United States who suffer from paralysis due to central nervous system disorders, autoimmune diseases, and spinal cord injuries. Blackrock’s MoveAgain BCI system is comprised of an array which, when implanted in the brain, has demonstrated in scientific studies that it can read, analyze, and ...
The groups were made up of 11 participants from the ABLE network who have a spinal cord injury and who had experience using exoskeletons for rehabilitation. ...
Henderson is Director of The Metropolitan Neurosurgery Group, LLC, Chief of Neurosurgery at Luminis Health at Doctors Hospital, staff at University of Maryland Capitol Region Medical Center and Director of the Chiari Syringomyelia Foundation Greater Metropolitan Washington Chapter, where he is focused on the development of the understanding and treatment of deformity induced ...
The Company intends to use the net proceeds from the offering for the following purposes: (i) sales, marketing and reimbursement expenses related to market development activities of the Company’s ReStore and Personal 6.0 devices, broadening third-party payor and CMS coverage for the ReWalk Personal device and commercializing its new product lines added through distribution agreements; (ii) ...
The Company intends to use the net proceeds from the offering for the following purposes: (i) sales, marketing and reimbursement expenses related to market development activities of the Company’s ReStore and Personal 6.0 devices, broadening third-party payor and CMS coverage for the ReWalk Personal device and commercializing its new product lines added through distribution agreements; (ii) ...